Cerus (CERS) Other financing activities (2013 - 2026)
Cerus (CERS) reported Other financing activities of $263000.0 for Q1 2026, down 19.33% on a YoY basis from $326000.0 in Q1 2025, and down 2.23% sequentially from $269000.0 in Q3 2025.
Cerus (CERS) Other financing activities (2013 - 2026) Analysis & Trends
Cerus (CERS) has 11 years of Other financing activities data on file, last reported at $263000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 19.33% year-over-year to $263000.0; the trailing twelve-month figure through Mar 2026 stood at $532000.0 (down 22.79% YoY), and the FY2025 full-year result was $595000.0, down 26.0% from the prior year.
- Other financing activities eased to $263000.0 in Q1 2026, from $269000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $2.1 million in Q1 2022 to a low of $263000.0 in Q1 2026.
- A 5-year average of $606454.5 and a median of $433000.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 198.9% in 2022, while the deepest fall reached 94.15% in 2022.
- Tracing CERS's Other financing activities over 5 years: stood at $490000.0 in 2022, then decreased by 11.63% to $433000.0 in 2023, then decreased by 16.17% to $363000.0 in 2024, then fell by 25.9% to $269000.0 in 2025, then fell by 2.23% to $263000.0 in 2026.
- Business Quant data shows CERS's Other financing activities at $263000.0 in Q1 2026, $269000.0 in Q3 2025, and $326000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263,000.00 |
| Mar 31, 2026 | 263,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Sep 30, 2024 | 363,000.00 |
| Sep 30, 2024 | 363,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 492,000.00 |
| Mar 31, 2023 | 492,000.00 |
| Dec 31, 2022 | 490,000.00 |
| Dec 31, 2022 | 490,000.00 |
| Sep 30, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 377,000.00 |
| Jun 30, 2022 | 377,000.00 |